Clindamycin in pure and mixed anaerobic infections.
D000038:Abscess / Q000188:drug therapy / Q000382:microbiology; D000328:Adult; D000332:Aerobiosis; D000693:Anaerobiosis; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy*; D001439:Bacteroides / Q000302:isolation & purification; D002981:Clindamycin / Q000627:therapeutic use*; D003013:Clostridium / Q000302:isolation & purification; D004646:Emphysema / Q000188:drug therapy / Q000382:microbiology; D004926:Escherichia coli / Q000302:isolation & purification; D005260:Female; D005673:Fusobacterium / Q000302:isolation & purification; D006801:Humans; D007416:Intestinal Perforation / Q000150:complications; D007709:Klebsiella / Q000302:isolation & purification; D008297:Male; D008875:Middle Aged; D010462:Peptostreptococcus / Q000302:isolation & purification; D011511:Proteus / Q000302:isolation & purification; D011549:Pseudomonas / Q000302:isolation & purification; D011552:Pseudomonas Infections / Q000150:complications; D014945:Wound Healing; D014947:Wounds and Injuries / Q000150:complications
D000900:Anti-Bacterial Agents; D002981:Clindamycin